vs
Beacon Financial Corp(BBT)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
Beacon Financial Corp的季度营收约是REPLIGEN CORP的1.1倍($216.7M vs $197.9M),Beacon Financial Corp净利率更高(24.6% vs 6.7%,领先17.9%),过去两年Beacon Financial Corp的营收复合增速更高(41.2% vs 14.4%)
倍肯屋面供应公司是北美知名的建筑材料供应商,主营住宅及非住宅类屋面产品及相关建材。截至2023年12月31日,公司在美国全部50个州和加拿大6个省共设有533个网点,员工超8000人,除屋面材料外,各地分部还销售门窗、壁板、防水材料等各类户外建筑产品。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
BBT vs RGEN — 直观对比
营收规模更大
BBT
是对方的1.1倍
$197.9M
净利率更高
BBT
高出17.9%
6.7%
两年增速更快
BBT
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $216.7M | $197.9M |
| 净利润 | $53.4M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 24.6% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | 179.4% | 143.9% |
| 每股收益(稀释后) | $0.55 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BBT
RGEN
| Q1 26 | $216.7M | — | ||
| Q4 25 | $225.7M | $197.9M | ||
| Q3 25 | $141.2M | $188.8M | ||
| Q2 25 | $113.7M | $182.4M | ||
| Q1 25 | $110.4M | $169.2M | ||
| Q4 24 | $110.2M | $174.1M | ||
| Q3 24 | $125.6M | $154.9M | ||
| Q2 24 | $108.7M | $154.1M |
净利润
BBT
RGEN
| Q1 26 | $53.4M | — | ||
| Q4 25 | $53.4M | $13.3M | ||
| Q3 25 | $-4.2M | $14.9M | ||
| Q2 25 | $22.0M | $14.9M | ||
| Q1 25 | $19.1M | $5.8M | ||
| Q4 24 | $17.5M | $-30.3M | ||
| Q3 24 | $20.1M | $-654.0K | ||
| Q2 24 | $16.4M | $3.3M |
毛利率
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | -5.9% | 8.9% | ||
| Q2 25 | 26.0% | 7.6% | ||
| Q1 25 | 23.1% | 3.9% | ||
| Q4 24 | 21.6% | -17.7% | ||
| Q3 24 | 21.3% | -5.1% | ||
| Q2 24 | 19.9% | 1.0% |
净利率
BBT
RGEN
| Q1 26 | 24.6% | — | ||
| Q4 25 | 23.6% | 6.7% | ||
| Q3 25 | -3.0% | 7.9% | ||
| Q2 25 | 19.4% | 8.2% | ||
| Q1 25 | 17.3% | 3.4% | ||
| Q4 24 | 15.9% | -17.4% | ||
| Q3 24 | 16.0% | -0.4% | ||
| Q2 24 | 15.1% | 2.2% |
每股收益(稀释后)
BBT
RGEN
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.64 | $0.24 | ||
| Q3 25 | $-0.05 | $0.26 | ||
| Q2 25 | $0.25 | $0.26 | ||
| Q1 25 | $0.21 | $0.10 | ||
| Q4 24 | $0.20 | $-0.55 | ||
| Q3 24 | $0.23 | $-0.01 | ||
| Q2 24 | $0.18 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $927.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.5B | $2.1B |
| 总资产 | $22.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
BBT
RGEN
| Q1 26 | $927.3M | — | ||
| Q4 25 | $1.8B | $767.6M | ||
| Q3 25 | $1.2B | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | $543.7M | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M |
总债务
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | $1.1B | $537.9M | ||
| Q2 25 | $225.6M | — | ||
| Q1 25 | $284.6M | — | ||
| Q4 24 | $1.5B | $525.6M | ||
| Q3 24 | $353.6M | — | ||
| Q2 24 | $278.6M | — |
股东权益
BBT
RGEN
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.1B | ||
| Q3 25 | $2.4B | $2.1B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B |
总资产
BBT
RGEN
| Q1 26 | $22.2B | — | ||
| Q4 25 | $23.2B | $2.9B | ||
| Q3 25 | $22.8B | $2.9B | ||
| Q2 25 | $12.0B | $2.9B | ||
| Q1 25 | $12.0B | $2.9B | ||
| Q4 24 | $11.9B | $2.8B | ||
| Q3 24 | $11.6B | $2.8B | ||
| Q2 24 | $12.2B | $2.9B |
负债/权益比
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.45× | 0.26× | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 1.24× | 0.27× | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势,按日历期对齐
经营现金流
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $25.7M | ||
| Q3 25 | $-4.8M | $48.1M | ||
| Q2 25 | $38.5M | $28.6M | ||
| Q1 25 | $23.3M | $15.0M | ||
| Q4 24 | $105.0M | $39.2M | ||
| Q3 24 | $19.9M | $49.3M | ||
| Q2 24 | $34.8M | $42.2M |
自由现金流
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | $-5.9M | $43.4M | ||
| Q2 25 | $36.3M | $21.5M | ||
| Q1 25 | $19.9M | $11.4M | ||
| Q4 24 | $100.0M | $33.6M | ||
| Q3 24 | $17.2M | $42.3M | ||
| Q2 24 | $34.4M | $37.4M |
自由现金流率
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | -4.2% | 23.0% | ||
| Q2 25 | 31.9% | 11.8% | ||
| Q1 25 | 18.0% | 6.8% | ||
| Q4 24 | 90.7% | 19.3% | ||
| Q3 24 | 13.7% | 27.3% | ||
| Q2 24 | 31.7% | 24.3% |
资本支出强度
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | 0.8% | 2.5% | ||
| Q2 25 | 1.9% | 3.9% | ||
| Q1 25 | 3.1% | 2.1% | ||
| Q4 24 | 4.5% | 3.2% | ||
| Q3 24 | 2.1% | 4.5% | ||
| Q2 24 | 0.3% | 3.1% |
现金转化率
BBT
RGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 1.75× | 1.92× | ||
| Q1 25 | 1.22× | 2.57× | ||
| Q4 24 | 5.99× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 2.12× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBT
| Net Interest Income | $190.8M | 88% |
| Noninterest Income | $25.9M | 12% |
RGEN
暂无分部数据